A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)

Clinical trial NCT02133508 · COMPLETED

Trial details

NCT number: NCT02133508
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer

Start date: 2014-04-30
Primary completion: 2016-06-10
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.